Rxo (RXO) Total Current Liabilities (2021 - 2026)

Rxo (RXO) has reported Total Current Liabilities for 6 consecutive years, with $1.0 billion the latest figure, recorded in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $1.0 billion, up 8.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 8.71% YoY), and the FY2025 annual result was $1.0 billion, down 2.54% from the prior year.
• Total Current Liabilities was $1.0 billion for Q1 2026 at Rxo, up from $1.0 billion in the prior quarter.
• Over five years, Total Current Liabilities peaked at $1.1 billion in Q4 2024 and troughed at $662.0 million in Q2 2024.
• Average Total Current Liabilities over 5 years is $855.0 million, with a median of $880.0 million recorded in 2025.
• Year-over-year, Total Current Liabilities declined 18.02% in 2023 and soared 56.16% in 2024.
• Over 5 years, Total Current Liabilities stood at $823.0 million in 2022, then decreased by 17.13% to $682.0 million in 2023, then jumped by 56.16% to $1.1 billion in 2024, then decreased by 2.54% to $1.0 billion in 2025, then increased by 0.96% to $1.0 billion in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $1.0 billion in Q1 2026, $1.0 billion in Q4 2025, and $907.0 million in Q3 2025.